6/18/2021  1:11:25 PM Chg. +0.0520 Volume Bid5:30:02 PM Ask2:10:24 PM Market Capitalization Dividend Y. P/E Ratio
0.3380EUR +18.18% 14,100
Turnover: 4,783
-Bid Size: - -Ask Size: - 2.73 mill.EUR 0.00% -

Business description

Elanix Biotechnologies Ltd. develops and commercializes tissue regeneration products for acute wound care, dermatological and gynecological applications, and provides services in cell technologies.
 

Management board & Supervisory board

CEO
-
Management board
Lee Ann Laurent-Applegate
Supervisory board
Anja Silling, Marco Christen, Yves Bonnard
 

Company data

Name: Elanix Biotechnologies AG
Address: Hanauer Landstraße 291 B,D-60314 Frankfurt am Main
Phone: +41-22-363-66-40
Fax: +41-22-363-66-41
E-mail: info@elanixbiotechnologies.ch
Internet: https://www.elanixbiotechnologies.ch/
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 62.57%
IPO date: -

Investor relations

Name: -
IR phone: -
IR Fax: -
IR e-mail: investor.relations@e...-bt.com investor.relations@elanix-bt.com

Main Shareholders

Freefloat
 
62.57%
Fang Bao
 
22.45%
Anja Silling
 
12.85%
Dr. Wassim Raffoul
 
2.13%